Article 1: Pharmacy Queues Growing in Bulgaria as Ivermectin is Made Available: The drug Huvemek, which contains the active ingredient ivermectin, is of great interest in hundreds of pharmacies across the country in Bulgaria, this, according to a BLIC reporter. This happened just a few days after the Medicines Executive Agency allowed the drug to be sold free of charge. https://trialsitenews.com/pharmacy-queues-growing-in-bulgaria-as-ivermectin-is-made-available-otc/ Article 2: Brazilian Pharmaceutical Company Counters Merck’s Position on Ivermectin Efficacy & Safety for COVID-19: In what can be considered a direct rebuttal to another ivermectin manufacturer in the United States, a Brazilian pharmaceutical manufacturer known as Vitamedic Indústria Farmacêutica recently issued a communication declaring that a report by the Merck-MSD drug group “on the effectiveness of Ivermectin in covid-19 treatment, shows its unique views on this issue.” The Brazilian company essentially communicated that Merck’s statement highlighted “its isolated opinion on the matter.” https://trialsitenews.com/brazilian-pharmaceutical-company-counters-mercks-position-on-ivermectin-efficacy-safety-for-covid-19/ Article 3: The End of COVID-19 Pandemic? Johns Hopkins’ Dr. Makary Says Probably: A February 18 Opinion piece in the Wall Street Journal is raising hopes, and possibly healthy skepticism, with its title and thesis being: “We’ll Have Herd Immunity by April.” The author is Dr. Martin Makary, a professor of health policy and management and public health expert at Johns Hopkins University. He notes that the media is under reporting on the dramatic fact that COVID-19 cases are down 77 percent just in the last six weeks. Largely this is, “because natural immunity from prior infection is far more common than can be measured by testing.” Applying some statistics to the case data, we could deduce the around 55 percent in the US have natural immunity. At the same time, vaccinations have been rolling out, and 15 percent of Americans have gotten a vaccine with the percentage rising fast. Based on these factors, “There is reason to think the country is racing toward an extremely low level of infection. As more people have been infected, most of whom have mild or no symptoms, there are fewer Americans left to be infected. At the current trajectory, I expect Covid will be mostly gone by April, allowing Americans to resume normal life.” https://trialsitenews.com/the-end-of-covid-19-pandemic-johns-hopkins-dr-makary-says-probably/ ... https://www.youtube.com/watch?v=TdTmplAe1Gs

Bree Burks talks about how Clinical trials have gone through a transformation since the onset of COVID-19. Where and when possible research sponsors are moving to remote, decentralized or so-called virtual trials. She also discusses the ongoing challenges with the study start-up process and how Veeva's SiteVault Free eRegulatory solution for Clinical Research Sites can help. Bree Burks: https://www.linkedin.com/in/bree-burks-78a26040/ Veeva Website: https://www.veeva.com/ ... https://www.youtube.com/watch?v=VkIznmKxN3c